The first coagulation monitoring device with built-in Bluetooth technology is expected to be commercially available this summer to warfarin patients in the United States, according to device-maker Roche Diagnostics.
Scientists are researching how to take stem cells from the patient’s blood to repair damage to the heart. A new therapy could reduce the need for operations, the U.K.’s Express newspaper reports, with researchers hoping the therapy could save lives while being cost effective.
Anheuser-Busch InBev decided to pull funding from a long-term study of moderate alcohol intake and its effects on cardiovascular health after concerns were raised about the objectivity of the research.
A scientist at the American Society of Clinical Oncology (ASCO)’s annual meeting discussed how cardiac imaging and biomarker measurements could improve care for cancer survivors.
Patients who utilize a healthy lifestyle smartphone application may be able to slow arterial aging, according to results from the EVIDENT II trial presented at EuroHeartCare 2018 in Dublin.
Patients who progressed to having longer episodes of subclinical atrial fibrillation (SCAF) were more than four times as likely to be hospitalized for heart failure in a one-year span, according to a study published June 4 in the Journal of the American College of Cardiology.
Measurements of malnutrition offer incremental prognostic value for patients with heart failure, but more work is needed to tease out which components of the condition are most crucial to calculate and treat, researchers reported in JACC: Heart Failure.
Minorities, specifically blacks and Hispanics, are more than twice as likely to have a second intracerebral hemorrhage than white counterparts, according to a new study published in Neurology on June 6.
The American Heart Association (AHA) expressed worry over the relatively flat rate of e-cigarette use among middle and high school students, saying the decline in tobacco use must continue before another generation becomes lifelong addicts.
